Skip to main content
Log in

The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background and objective

Freezing of gait (FOG) is a disabling symptom more frequent in Parkinson’s disease (PD) patients with postural instability gait difficulty (PIGD) phenotype. The aim of this study was to determine the prevalence of self-reported FOG in a large group of PD patients as well as assess its relationship with functional dependency with regard to motor phenotype.

Methods

The data correspond to the baseline evaluation of the COPPADIS-2015 study. Patients with FOG were identified as those with a score of 1 or greater on item-3 of the freezing of gait questionnaire (FOG-Q). Functional dependency was defined as a Schwab and England (S&E) ADL scale score less than 80%. PIGD and non-PIGD (tremor dominant + indeterminate) groups were considered regarding to motor phenotype.

Results

Among the 689 PD patients (62.6 ± 8.9 years old, 59.8% males), 240 reported FOG (34.8%), whereas 63 presented functional dependency (9.1%). A total of 22.1% of patients with FOG presented functional dependency vs. only 2.2% of those without FOG (p < 0.0001). FOG was related to functional dependency (OR = 3.470; 95%CI 1.411–8.530; p = 0.007) after adjustment to age, gender, disease duration, daily equivalent levodopa dose, comorbidity (number of non-antiparkinsonian drugs/day), motor status (UPDRS-III), PIGD phenotype, motor complications (UPDRS-IV), NMS burden (NMSS total score), cognition (PD-CRS), and mood (BDI-II). However, according to motor phenotype, FOG was related to functional dependency only in PIGD patients (OR = 7.163; 95%CI 1.206–42.564; p = 0.030).

Conclusions

Self-reported FOG is associated with functional dependency in PIGD but not in non-PIGD motor phenotype patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

FOG:

Freezing of gait

FOG-Q:

Freezing of gait questionnaire

NMSS:

Non-motor symptoms scale

PD:

Parkinson’s disease

PD-CRS:

Parkinson’s disease cognitive rating scale

PIGD:

Postural instability gait difficulty

S&E:

Schwab & England activities of daily living scale

TD:

Tremor dominant

UPDRS:

Unified Parkinson’s disease rating scale

References

  1. Covinsky KE, Palmer RM, Fortinsky RH, Counsell SR, Stewart AL, Kresevic D, Burant CJ, Landefeld CS (2003) Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc 51:451–458

    Article  Google Scholar 

  2. Macleod AD, Dalen I, Tysnes OB, Larsen JP, Counsell CE (2017) Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease. Mov Disord 33:108–116

    Article  Google Scholar 

  3. Bjornestad A, Tysnes OB, Larsen JP, Alves G (2016) Reliability of three disability scales fo detection of independence loss in Parkinson’s disease. Parkinsons Dis 2016:1941034

    PubMed  PubMed Central  Google Scholar 

  4. Macleod AD, Counsell CE (2016) Predictors of functional dependency in Parkinson’s disease. Mov Disord 31:1482–1148

    Article  Google Scholar 

  5. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ, CARPA Study Group (2008) Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 70:2241–2247

    Article  CAS  Google Scholar 

  6. Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Schelosky L, Tison F, Rascol O (2014) Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol 71:884–890

    Article  Google Scholar 

  7. Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C, Parkinson Study Group (2001) Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56:1712–1721

    Article  CAS  Google Scholar 

  8. Wu Y, Guo XY, Wei QQ, Ou RW, Song W, Cao B, Zhao B, Shang HF (2016) Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson’s disease patients. Acta Neurol Scand 133:330–337

    Article  CAS  Google Scholar 

  9. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov Disord 28:668–670

    Article  Google Scholar 

  10. Macleod AD, Grieve JW, Counsell CE (2016) A systematic review of loss of independence in Parkinson’s disease. J Neurol 263:1–10

    Article  Google Scholar 

  11. Santos García D, Jesús S, Aguilar M, Planellas LL, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, López Díaz L, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, Fábregues-Boixar O, González Ardura J, Prieto Jurczynska C, Martinez-Martin P, Mir P, on behalf of the COPPADIS Study Group, Adarmes Astrid D, Almeria M, Alonso Cánovas A, Alonso Frech F, Aneiros Díaz A, Arnáiz S, Arribas S, Ascunce Vidondo A, Bernardo Lambrich N, Bejr-Kasem H, Blázquez Estrada M, Botí M, Cabello González C, Cámara Lorenzo A, Carrillo F, Casas E, Clavero P, Cortina Fernández A, Cots Foraster A, Crespo Cuevas A, de Deus Fonticoba T, Díez-Fairen M, Erro E, Estelrich Peyret E, Fernández Guillán N, Gámez P, Gallego M, García Campos C, Gómez Garre MP, González Aloy J, González García B, González Palmás MJ, González Toledo GR, Golpe Díaz A, Grau Solá M, Guardia G, Horta-Barba A, Infante J, Labandeira C, Labrador MA, Lacruz F, Lage Castro M, López Seoane B, Macías Y, Mata M, Martí Andres G, Martí MJ, McAfee D, Meitín MT, Méndez del Barrio C, Miranda Santiago J, Morales Casado MI, Moreno Diéguez A, Nogueira V, Novo Amado A, Novo Ponte S, Ordás C, Pagonabarraga J, Pareés I, Pascual-Sedano B, Pastor P, Pérez Fuertes A, Pérez Noguera R, Prats MA, Pueyo Morlans M, Redondo Rafales N, Rodríguez Méndez L, Rodríguez Pérez AB, Roldán F, Ruíz de Arcos M, Sánchez-Carpintero M, Sánchez Díez G, Sánchez Rodríguez A, Santacruz P, Segundo Rodríguez JC, Serarols A, Sierra Peña M, Suárez Castro E, Tartari JP, Vargas L, Vázquez Gómez R, Villanueva C, Vives B, Villar MD (2019) COPPADIS Study Group. COPPADIS-2015 (COhort of Patient’s with PArkinson’s DIsease in Spain, 2015): an ongoing global Parkinson’s disease project about disease progression with more than 1,000 subjects included. Results from the baseline evaluation. Eur J Neurol 26:1399–1407

    Article  Google Scholar 

  12. Santos-García D, Mir P, Cubo E, COPPADIS Study Group et al (2016) COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global-clinical evaluations, serum biomarkers, genetic studies and neuroimaging-prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression. BMC Neurol 16:26

    Article  Google Scholar 

  13. Amboni M, Stocchi F, Abbruzzese G, Morgante L, Onofrj M, Ruggieri S, Tinazzi M, Zappia M, Attar M, Colombo D, Simoni L, Ori A, Barone P, Antonini A, DEEP Study Group; DEEP Study Group (2015) Prevalence and associated features of self-reported freezing of gait in Parkinson disease: the DEEP FOG study. Parkinsonism Relat Disord 21:644–649

    Article  CAS  Google Scholar 

  14. Santos-García D, de Deus FT, Suárez Castro E, COPPADIS Study Group et al (2019) High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients. J Neural Transm (Vienna) 126:1599–1608

    Article  Google Scholar 

  15. Cohen J, Cohen P (1983) Applied multiple regression/correlation analysis for the behavioral sciences, Second edn. Lawrence Erlbaum, Hillsdale

    Google Scholar 

  16. Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M (2017) Comorbid conditions associated with Parkinson’s disease: a longitudinal and comparative study with Alzheimer disease and control subjects. J Neurol Sci 373:210–215

    Article  Google Scholar 

  17. Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, Yeung E (2012) Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry 83:607–611

    Article  Google Scholar 

  18. Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ (2012) Loss of ability to work and ability to live independently in Parkinson’s disease. Parkinsonism Relat Disord 18:130–135

    Article  Google Scholar 

  19. Scigliano G, Musicco M, Soliveri P, Girotti F, Giovannini P, Fetoni V, Caraceni T (1996) Progression and prognosis in Parkinson’s disease in relation to concomitant cerebral or peripheral vasculopathy. Adv Neurol 69:305–309

    CAS  PubMed  Google Scholar 

  20. Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N, Mochizuki H, Hattori N, Mori H, Mizuno Y, Juntendo Parkinson Study Group; Parkinson Study G (2006) Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21:1384–1395

    Article  Google Scholar 

  21. Velseboer DC, Broeders M, Post B, van Geloven N, Speelman JD, Schmand B, de Haan RJ, de Bie RMA, on behalf of the CARPA Study Group (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80:627–633

    Article  Google Scholar 

  22. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2005) Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65:1436–1441

    Article  Google Scholar 

  23. Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU (2010) Frequency of dementia, depression, and other neu-ropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease. J Neurol 257:1073–1082

    Article  Google Scholar 

  24. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leenjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189

    Article  Google Scholar 

  25. Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H (2011) Postural instability/gait disturbance in Parkin-son’s disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry 82:564–568

    Article  Google Scholar 

  26. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G (2015) 12-year population-based study of freezing of gait in Parkinson’s disease. Parkinsonism Relat Disord 21:254–258

    Article  CAS  Google Scholar 

  27. Behari M, Srivastava AK, Pandey RM (2005) Quality of life in patients with Parkinson’s disease. Parkinsonism Relat Disord 11:221–226

    Article  CAS  Google Scholar 

  28. Walton CC, Shine JM, Hall JM, O’Callaghan C, Mowszowski L, Gilat M, Szeto JYY, Naismith SL, Lewis SJG (2015) The major impact of freezing of gait on quality of life in Parkinson’s disease. J Neurol 262:108–115

    Article  CAS  Google Scholar 

  29. Bowman T, Gervasoni E, Parelli R, Jonsdottir J, Ferrarin M, Cattaneo D, Carpinella I (2018) Predictors of mobility domain of health-related quality of life after rehabilitation in Parkinson’s disease: a pilot study. Arch Physiother 8:10

    Article  Google Scholar 

  30. Ginis P, Nieuwboer A, Dorfman M, Ferrari A, Gazit E, Canning CG, Rocchi L, Chiari L, Hausdorff JM, Mirelman A (2016) Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson’s disease: a pilot randomized controlled trial. Parkinsonism Relat Disord 22:28–34

    Article  Google Scholar 

  31. Santos García D, de Deus FT, Borrué C et al (2019) Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson’s disease patients: results from the COPPADIS Study Cohort. Parkinsonism Relat Disord 66:151–157

    Article  Google Scholar 

  32. Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J (2019) Clinical and methodological challenges for assessing freezing of gait: future perspectives. Mov Disord 34:783–790

    Article  Google Scholar 

  33. Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ (2019) Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism Relat Disord 65:178–183

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank all patients, caregivers, and all persons, companies, or institutions collaborating in this project. Especially, many thanks to Fundación Curemos el Parkinson (www.curemoselparkinson.org) and Alphabioresearch (www.alphabioresearch.com). The following are the collaborators of the COPPADIS STUDY GROUP: Adarmes Astrid D, Almeria M, Alonso Cánovas A, Alonso Frech F, Arnáiz S, Arribas S, Ascunce Vidondo A, Aguilar M, Bernardo Lambrich N, Bejr-Kasem H, Blázquez Estrada M, Botí M, Borrue C, Cabello González C, Cabo López I, Cámara Lorenzo A, Carrillo F, Carrillo Padilla FJ, Casas E, Clavero P, Cortina Fernández A, Cosgaya M, Cots Foraster A, Crespo Cuevas A, de Fábregues-Boixar O, Díez-Fairen M, Erro E, Estelrich Peyret E, Fernández Guillán N, Gámez P, Gallego M, García Campos C, García Moreno JM, Gastón I, Guillén Fopiani D, Gómez Garre MP, González Aloy J, González Ardura J, González García B, González Palmás MJ, González Toledo GR, Golpe Díaz A, Grau Solá M, Guardia G, Horta-Barba A, Idoate Calderón D, Infante J, Kulisevsky J, Kurtis M, Labandeira C, Labrador MA, Lacruz F, Lage Castro M, López Díaz LM, López Manzanares L, López Seoane B, Lucas del Pozo, Macías Y, Mata M, Martí Andres G, Martí MJ, Martínez Castrillo JC, McAfee D, Meitín MT, Menéndez González M, Méndez del Barrio C, Miranda Santiago J, Morales Casado MI, Moreno Diéguez A, Nogueira V, Novo Amado A, Novo Ponte S, Ordás C, Pagonabarraga J, Pareés I, Pascual-Sedano B, Pastor P, Pérez Fuertes A, Pérez Noguera R, Prats MA, Prieto Jurczynska C, Puente V, Pueyo Morlans M, Redondo Rafales N, Rodríguez Méndez L, Rodríguez Pérez AB, Roldán F, Ruíz De Arcos M, Ruíz Martínez J, Sánchez-Carpintero M, Sánchez Díez G, Sánchez Rodríguez A, Santacruz P, Segundo Rodríguez JC, Seijo M, Sierra Peña M, Solano Vila B, Tartari JP, Valero C, Vargas L, Villanueva C, Vives B, and Villar MD.

Funding

Santos-García D. has received honoraria for educational presentations and/or advice service by Abbvie, UCB Pharma, Lundbeck, KRKA, Zambon, Bial, and Teva.

de Deus Fonticoba T. has received honoraria for educational presentations and advice service by Abbvie. Suárez Castro E: None. Ángel Aneiros Díaz: None. Feal Painceiras M: None. Paz González JM has received honoraria for educational presentations and/or advice service by UCB Pharma, Lundbeck, KRKA y Zambon. García Sancho C: None. Jesús S. has received honoraria from AbbVie, Bial, Merz, UCB, and Zambon. She also holds the competitive contract “Juan Rodés” supported by the Instituto de Salud Carlos III. She has received grants from the Spanish Ministry of Economy and Competitiveness (PI18/01898) and the Consejería de Salud de la Junta de Andalucía (PI-0459-2018). Mir P. has received honoraria from AbbVie, Abbott, Allergan, Bial, Merz, UCB, and Zambon. Also, he has received grants from the Spanish Ministry of Economy and Competitiveness (PI16/01575) co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación), Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0437-2012, PI-0471-2013), the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, and the Fundación Mutua Madrileña. Planellas LL. has received travel bursaries grant from Abbvie. García Caldentey J. has received honoraria for educational presentations and advice service by Qualigen, Nutricia, Abbvie, Italfarmaco, UCB Pharma, Lundbeck, Zambon, Bial, and Teva. Caballol N. has received honoraria for educational presentations and advice service by Qualigen, Nutricia, Abbvie, Italfarmaco, UCB Pharma, Lundbeck, Zambon, Bial, and Teva. Legarda I. has received honoraria for educational presentations and advice service by Abbvie, UCB Pharma, Zambon, Bial, and Teva. Hernández Vara J. has received travel bursaries and educational grants from Abbvie and has received honoraria for educational presentations from Abbvie, Teva, Bial, Zambon, Italfarmaco, and Sanofi-Genzyme. González Aramburu I: None. Ávila Rivera MA. has received honoraria from Zambon, UCB Pharma, Qualigen, Bial, and Teva, and sponsorship from Zambon and Teva for attending conferences. Catalán MJ: None. Nogueira V: None. Álvarez Sauco M. has received honoraria for educational presentations and advice service by Abbvie, UCB Pharma, Zambon, Bial, and Teva. Vela L. has received honoraria for educational presentations and advice service by Abbvie, UCB Pharma, Lundbeck, KRKA, Zambon, Bial, and Teva. Escalante S. has received honoraria for educational presentations and advice service by Abbvie, Zambon, and Bial. Cubo E: travel grants: Abbvie, Allergan, Boston; lecturing honoraria: Abbvie, International Parkinson’s disease Movement Disorder Society. Sánchez Alonso P. has received honoraria for educational presentations and advice service by Abbvie, UCB Pharma, Lundbeck, KRKA, Zambon, Bial, and Teva. Alonso Losada MG. has received honoraria for educational presentations and advice service by Zambon and Bial. López Ariztegui N. has received honoraria for educational presentations and advice service by Abbvie, Italfarmaco, Zambon, and Bial. Martinez-Martin P: Honoraria: from Editorial Viguera and National School of Health for lecturing in courses; International Parkinson and Movement Disorder Society for management of the Program on Rating Scales; Abbvie and Zambon for advice in clinic-epidemiological studies www.curemoselparkinson.org.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

Santos-García D: conception, organization, and execution of the project; statistical analysis; writing of the first draft of the manuscript; recruitment and/or evaluation of participants. De Deus Fonticoba T: review and critique; recruitment and/or evaluation of participants. Suárez Castro E: review and critique; recruitment and/or evaluation of participants. Ángel Aneiros Díaz: review and critique; recruitment and/or evaluation of participants. Feal Painceiras M: review and critique. Paz González JM: review and critique. García Sancho C: review and critique. Jesús S: review and critique; recruitment and/or evaluation of participants. Mir P: review and critique; recruitment and/or evaluation of participants. Planellas LL: review and critique; recruitment and/or evaluation of participants. García Caldentey J: review and critique; recruitment and/or evaluation of participants. Caballol N: review and critique; recruitment and/or evaluation of participants. Legarda I: review and critique; recruitment and/or evaluation of participants. Hernández Vara J: review and critique; recruitment and/or evaluation of participants. González Aramburu I: review and critique; recruitment and/or evaluation of participants. Ávila Rivera MA: review and critique; recruitment and/or evaluation of participants. Catalán MJ: review and critique; recruitment and/or evaluation of participants. Víctor Nogueira: review and critique; recruitment and/or evaluation of participants. Álvarez Sauco M: review and critique; recruitment and/or evaluation of participants. Vela L: review and critique; recruitment and/or evaluation of participants. Escalante S: review and critique; recruitment and/or evaluation of participants. Cubo E: review and critique; recruitment and/or evaluation of participants. Sánchez Alonso P: review and critique; recruitment and/or evaluation of participants. Alonso Losada MG: review and critique; recruitment and/or evaluation of participants. López Ariztegui N: review and critique; recruitment and/or evaluation of participants. Martinez-Martin P: review and critique; overall supervision.

Corresponding author

Correspondence to Diego Santos-García.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The authors received approval from the appropriate local and national ethical standards committee.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santos-García, D., de Deus-Fonticoba, T., Suárez Castro, E. et al. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype. Neurol Sci 41, 2883–2892 (2020). https://doi.org/10.1007/s10072-020-04404-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04404-7

Keywords

Navigation